Abstract-Substituted quinazolone salicylhydrazides exhibiting anticonvulsant activity against pentylenetetrazol and maximal electric shock (MES) seizures were found to potentiate nembutal induced hypnosis in mice. All these compounds were found to inhibit selectively in vitro oxidation of pyruvic acid and a-ketoglutaric acid. The relative electronegativity of the substituents at position 6 of the quinazolone nucleus in no way paralleled their enzyme inhibitory effects.
Increase in the concentration of brain biogenic amines has been suggested to be in some way related to the anticonvulsant activity of monoamine oxidase inhibitors (1, 2).
The ability of 2, 3-disubstituted quinazolones to exhibit anticonvulsant (3) and hypnotic properties (4) led us to investigate the central nervous system (CNS) depressant activity of quinazolone salicylhydrazides (5) against maximal electric shock (MES) and pentylenetetrazol induced seizures. The effect of these monoamine oxidase inhibitors (6) was also investigated on the duration of hypnosis induced by the administration of pentobarbitone. Attempts to elucidate molecular mechanism of action prompted us to correlate the CNS depressant activity of these hydrazides with their in vitro effect on the oxidation of nicotinamide adenine dinucleotide (NAD) dependent as well as NAD-independent oxidations by rat brain homogenate.
METHODS
The synthesis of newer 2, 3-disubstituted 2, 3, 6-trisubstituted and 2, 3, 6, 8-tetrasubstituted quinazolones and their in vitro effect on the monoamine oxidase activity of rat liver homogenate using tyramine as substrate have been reported earlier (5, 6) . In the present study anti-convulsant activity against pentylenetetrazol, maximal electric shock (MES) seizures, plus the effect on the duration of pentobarbitone hypnosis and the in vitro effect on the oxidation of NAD-dependent oxidation by rat brain homogenate has been investigated.
1.
Anticonvulsant activity Salicyl hydrazides were tested against pentylenetetrazol (Metrazol) and MES induced seizures in albino mice weighing between 20-26 g. The mice were divided in groups of 10, keeping the group weights equal as far as possible. One group of animals was used ET AL.
for one dose of the test compound. The compounds were suspended in 5 % aqueous gum acacia and were administered intraperitoneally.
i) Metrazol seizures threshold test (7) Four hr after administration of the compounds pentylenetetrazol was injected subcutaneously in a dose of 80 mg/kg under the loose skin of the back. This dose of pentylenetetrazol has been shown to cause convulsions in almost all normal animals. The animals were observed for the next 60 min for the occurrence of seizures. One episode of clonic spasm which persisted for at least a five sec period was considered a threshold convulsion. No consideration was made for the observed transient intermittent jerks or tremulousness. Animals not exhibiting even a threshold convulsion during the 60 min period were considered protected. The number of animals protected in each group was recorded and the percentage protection was calculated (Table 1) .
ii) Maximal electroshock seizures test (8) The mice were stimulated 4 hr after the administration of the compounds, through corneal electrodes with shocks of 1 msec duration 50/sec frequency and 35-50 volts amplitude per 0.3 sec. The resultant normal seizure showed a tonic phase of limb flexion followed by full tonic extension, and a few clonic jerks thereafter. The electrodes were secured in positions by special clamps applied to the eye lids. The end point taken was the abolition of the hind leg tonic extensor component of the seizure and the percentage protection was recorded for each compound ( Table 1 ). The minimum protection was afforded by QZS-3, having Br substituent at 6 position, whereas maximum protection was found with QZS-6 with bromo substituent at both 6 and 8 posi- Compound number refers to compounds described in Table 1 . Assay procedure and vessel contents are as described in the text. Percent inhibition was calculated from the decrease in oxygen uptake per 100 mg of fresh weight per hr. All experiments were duplicated and the values are the mean of two sets of experiments.
tions against both types of seizures. These compounds, possessing in vitro MAO inhibitory activity (6) were also found to prolong pentobarbitone induced hypnosis in mice.
The maximum potentiation of hypnosis was observed with QZS-2 having chloro substituent at position 6. As is evident from Table 1 
